Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05857943 · ClinicalTrials.gov registry record · NA
Efficacy and Safety of AEYE-DS Software Device for Automated Detection of Diabetic Retinopathy From Digital Funduscopic Images
A NA study, sponsored by AEYE Health.
- Completed
- Registry status
- NA
- Development phase
- 363
- Enrollment target
NCT05857943 is a NA study that has completed, run by AEYE Health. The registered enrollment target is 363 participants.
The verdict
NCT05857943, a NA study, has completed, sponsored by AEYE Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 363 participants
- Enrollment target
Study Summary
AEYE-DS is a software device developed to increase compliance with diabetic retinopathy screening by automatically detecting more-than-mild diabetic retinopathy from digital funduscopic images using AI-based software. This study has been designed to validate the safety and efficacy of the device at primary care and other point of care sites.
Interventions
- DEVICE AEYE-DS Software
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 363 participants |
| Start Date | 2023-03-29 |
| Est. Completion | 2023-10-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05857943
The ClinicalTrials.gov registry entry for NCT05857943 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 363 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AEYE Health, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AEYE-DS Software is the first listed.
NCT05857943 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05857943 about?
NCT05857943 is a clinical study titled "Efficacy and Safety of AEYE-DS Software Device for Automated Detection of Diabetic Retinopathy From Digital Funduscopic Images". AEYE-DS is a software device developed to increase compliance with diabetic retinopathy screening by automatically detecting more-than-mild diabetic retinopathy from digital funduscopic images using AI-based software. This study has been designed to validate the safety and efficacy of the device at ...
What is the current status of trial NCT05857943?
This trial is currently completed. It is a NA study. The enrollment target is 363 participants. The study started on 2023-03-29. Estimated completion is 2023-10-10.
What interventions are being tested in trial NCT05857943?
The interventions under investigation include: AEYE-DS Software (DEVICE).
Who is sponsoring clinical trial NCT05857943?
This trial is sponsored by AEYE Health, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.